Qinglian Zhai
State Key Laboratory Of Oncology In South China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population.
Journal: Annals of medicine
Published: August 16, 2021
CPSF4 promotes triple negative breast cancer metastasis by upregulating MDM4.
Journal: Signal transduction and targeted therapy
Published: September 12, 2020
Metronomic chemotherapy of cyclophosphamide plus methotrexate for advanced breast cancer: Real-world data analyses and experience of one center.
Journal: Cancer communications (London, England)
Published: November 20, 2019
Administration of Lapatinib with Food Increases Its Plasma Concentration in Chinese Patients with Metastatic Breast Cancer: A Prospective Phase II Study.
Journal: The oncologist
Published: October 30, 2019
Local treatment for liver oligometastases in breast cancer patients: identification of prognostic factors and exploration of appropriate treatment strategy.
Journal: Translational cancer research
Published: August 29, 2019
NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer.
Journal: Nature communications
Published: October 27, 2018
CDK4/6 inhibitor palbociclib enhances the effect of pyrotinib in HER2-positive breast cancer.
Journal: Cancer letters
Published: October 09, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026